A phase 3 trial with a 2x2 factorial design of abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo metastatic castration-sensitive prostate cancer (mCSPC): First results of PEACE-1.

Affiliation auteurs!!!! Error affiliation !!!!
TitreA phase 3 trial with a 2x2 factorial design of abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo metastatic castration-sensitive prostate cancer (mCSPC): First results of PEACE-1.
Type de publicationJournal Article
Year of Publication2021
AuteursFizazi K, Maldonado X, Foulon S, Roubaud G, McDermott RS, Flechon A, Tombal BF, Supiot S, Berthold DR, Ronchin P, Kacso G, Gravis G, Calabro F, Berdah JFrancois, Hasbini A, Silva M, Thiery-Vuillemin A, Rieger I, Tanguy MLaure, Bossi A
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume39
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2021.39.15_suppl.5000